133 related articles for article (PubMed ID: 20121689)
1. Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian.
Christou EM; Damian DL; Thompson JF
Med J Aust; 2010 Feb; 192(3):171. PubMed ID: 20121689
[No Abstract] [Full Text] [Related]
2. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.
Arpaia N; Cassano N; Vena GA
Int J Dermatol; 2006 Aug; 45(8):952-6. PubMed ID: 16911383
[No Abstract] [Full Text] [Related]
3. Metastatic malignant melanoma associated with vitiligo-like depigmentation.
Wang JR; Yu KJ; Juan WH; Yang CH
Clin Exp Dermatol; 2009 Mar; 34(2):209-11. PubMed ID: 18691245
[TBL] [Abstract][Full Text] [Related]
4. Metastatic melanoma of the transverse colon heralded by vitiligo-like depigmentation: two rare conditions occurring in the same patient.
Virgilio E; Sandomenico R; Fransvea P; Balducci G
Clin Exp Dermatol; 2015 Jun; 40(4):453-5. PubMed ID: 25438833
[No Abstract] [Full Text] [Related]
5. [Vitiliginous depigmentation in patients suffering from malignant melanoma].
Frenk E
Dermatologica; 1969; 139(1):84-91. PubMed ID: 5810156
[No Abstract] [Full Text] [Related]
6. Depigmentation: its significance in patients with melanoma.
Barnes L; Nordlund JJ
Clin Dermatol; 1989; 7(2):66-73. PubMed ID: 2667742
[No Abstract] [Full Text] [Related]
7. Vitiligo-like hypopigmentation and metastatic melanoma of unknown primary site: friends or foes?
Salas-Alanis JC; Gonzalez R; Fortuna G
Med Oncol; 2012 Dec; 29(4):2963-5. PubMed ID: 22203381
[No Abstract] [Full Text] [Related]
8. Vitiligo associated with metastatic malignant melanoma.
Cavallari V; Cannavò SP; Ussia AF; Moretti G; Albanese A
Int J Dermatol; 1996 Oct; 35(10):738-40. PubMed ID: 8891830
[No Abstract] [Full Text] [Related]
9. An amelanotic melanoma transformed into melanotic melanoma with development of vitiligo.
Takematsu H; Tomita Y; Sato A; Seiji M
J Dermatol; 1981 Dec; 8(6):431-8. PubMed ID: 7037894
[No Abstract] [Full Text] [Related]
10. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
[TBL] [Abstract][Full Text] [Related]
11. Metastatic melanoma and vitiligo: a case report.
Buljan M; Situm M; Lugović L; Vucić M
Acta Dermatovenerol Croat; 2006; 14(2):100-3. PubMed ID: 16859616
[TBL] [Abstract][Full Text] [Related]
12. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
[No Abstract] [Full Text] [Related]
13. [Adhesive tape induced depigmentation. An ultrastructural study and comparison with vitiligo and vitiliginous depigmentation associated with melanoma (author's transl)].
Frenk E; Kocsis M
Dermatologica; 1974; 148(5):276-84. PubMed ID: 4420330
[No Abstract] [Full Text] [Related]
14. Prolonged survival in metastatic malignant melanoma associated with vitiligo.
Duhra P; Ilchyshyn A
Clin Exp Dermatol; 1991 Jul; 16(4):303-5. PubMed ID: 1794178
[TBL] [Abstract][Full Text] [Related]
15. Melanoma of unknown primary with nodal metastases, presenting with vitiligo-like depigmentation.
Manganoni AM; Farfaglia R; Sereni E; Farisoglio C; Pavoni L; Calzavara-Pinton PG
G Ital Dermatol Venereol; 2012 Apr; 147(2):210-1. PubMed ID: 22481586
[No Abstract] [Full Text] [Related]
16. Case 1. Melanoma in African Americans.
Dowell JE; Shen Y; Harford WV; Lai WS
J Clin Oncol; 2005 May; 23(15):3622-4. PubMed ID: 15908673
[No Abstract] [Full Text] [Related]
17. Vitiligo-like depigmentation and morpheas after specific intralymphatic immunotherapy for malignant melanoma.
Lacour JP; Caldani C; Thyss A; Schneider M; Ortonne JP
Dermatology; 1992; 184(4):283-5. PubMed ID: 1498395
[TBL] [Abstract][Full Text] [Related]
18. The course of melanoma-associated vitiligo: report of a case.
Daneshpazhooh M; Shokoohi A; Dadban A; Raafat J
Melanoma Res; 2006 Aug; 16(4):371-3. PubMed ID: 16845334
[TBL] [Abstract][Full Text] [Related]
19. Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab.
Gracia-Cazaña T; Padgett E; Hernández-García A; Sánchez-Salas MP
Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045170
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset leukoderma and malignant melanoma.
Gross DJ; Singer PG; Schosser RH
Arch Dermatol; 1990 Sep; 126(9):1240-1. PubMed ID: 2396849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
